Increased migration of human mesenchymal stromal cells by autocrine motility factor (amf) resulted in enhanced recruitment towards hepatocellular carcinoma

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Bayo, Juan ^a   Fiore, Esteban ^a   Aquino, Jorge B ^a,b   Malvicini, Mariana ^a   Rizzo, Manglio ^b   Peixoto, Estanislao ^a   Andriani, Oscar ^a   Alaniz, Laura ^a   Piccioni, Flavia ^a,b   Bolontrade, Marcela ^a   Podhajcer, Osvaldo ^b,c   Garcia, Mariana G ^a,b   Mazzolini, Guillermo ^a,b  

^a UNIVERSIDAD AUSTRAL   (Argentina)

^b Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

^c FUNDACIÓN INSTITUTO LELOIR   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOCRINE MOTILITY FACTOR RECEPTOR; CAVEOLIN 1; CAVEOLIN 2; GELATINASE A; GLUCOSE 6 PHOSPHATE ISOMERASE; STROMELYSIN; METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FLUORESCENCE IMAGING; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MESENCHYMAL STROMA CELL; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; NORMAL HUMAN; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; ZYMOGRAPHY; ANIMAL; CELL MOTION; CHEMOTAXIS; DISEASE MODEL; DRUG EFFECTS; ENZYME ACTIVATION; GENETICS; LIVER TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOTAXIS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GLUCOSE-6-PHOSPHATE ISOMERASE; HETEROGRAFTS; HUMANS; LIVER NEOPLASMS; MALE; MESENCHYMAL STROMAL CELLS; METALLOENDOPEPTIDASES; MICE; TUMOR BURDEN;

EID: 84899678951     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095171     Document Type: Article

References (37)

1. Ferenci P, Fried M, Labrecque D, Bruix J, Sherman M, et al. (2010) World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective. J Gastrointestin Liver Dis 19: 311-317.
2. de Lope CR, Tremosini S, Forner A, Reig M, Bruix J (2012) Management of HCC. J Hepatol 56 Suppl 1: S75-87.
3. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317. (Pubitemid 44269669)
4. Bernardo ME, Locatelli F, Fibbe WE (2009) Mesenchymal stromal cells. Ann N Y Acad Sci 1176: 101-117.
5. Prockop DJ, Oh JY (2012) Medical therapies with adult stem/progenitor cells (MSCs): a backward journey from dramatic results in vivo to the cellular and molecular explanations. J Cell Biochem 113: 1460-1469.
6. Bayo J, Marrodan M, Aquino JB, Silva M, Garcia MG, et al. (2013) The therapeutic potential of bone marrow-derived mesenchymal stromal cells on hepatocellular carcinoma. Liver Int.
7. Liotta LA, Mandler R, Murano G, Katz DA, Gordon RK, et al. (1986) Tumor cell autocrine motility factor. Proc Natl Acad Sci U S A 83: 3302-3306. (Pubitemid 16043024)
8. Watanabe H, Takehana K, Date M, Shinozaki T, Raz A (1996) Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. Cancer Res 56: 2960-2963. (Pubitemid 26199739)
9. Shimizu K, Tani M, Watanabe H, Nagamachi Y, Niinaka Y, et al. (1999) The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein. FEBS Lett 456: 295-300. (Pubitemid 29352311)
10. Le PU, Guay G, Altschuler Y, Nabi IR (2002) Caveolin-1 is a negative regulator of caveolae-mediated endocytosis to the endoplasmic reticulum. J Biol Chem 277: 3371-3379. (Pubitemid 34953205)
11. Dobashi Y, Watanabe H, Sato Y, Hirashima S, Yanagawa T, et al. (2006) Differential expression and pathological significance of autocrine motility factor/ glucose-6-phosphate isomerase expression in human lung carcinomas. J Pathol 210: 431-440. (Pubitemid 44830603)
12. Baumann M, Kappl A, Lang T, Brand K, Siegfried W, et al. (1990) The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer. Cancer Invest 8: 351-356. (Pubitemid 20352768)
13. Torimura T, Ueno T, Kin M, Harada R, Nakamura T, et al. (2001) Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins. Hepatology 34: 62-71. (Pubitemid 32591484)
14. Yu FL, Liao MH, Lee JW, Shih WL (2004) Induction of hepatoma cells migration by phosphoglucose isomerase/autocrine motility factor through the upregulation of matrix metalloproteinase-3. Biochem Biophys Res Commun 314: 76-82.
15. Tsutsumi S, Gupta SK, Hogan V, Collard JG, Raz A (2002) Activation of small GTPase Rho is required for autocrine motility factor signaling. Cancer Res 62:4484-4490. (Pubitemid 34827312)
16. Haga A, Funasaka T, Deyashiki Y, Raz A (2008) Autocrine motility factor stimulates the invasiveness of malignant cells as well as up-regulation of matrix metalloproteinase-3 expression via a MAPK pathway. FEBS Lett 582: 1877-1882.
17. Hu J, Dong A, Fernandez-Ruiz V, Shan J, Kawa M, et al. (2009) Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma. Cancer Res 69: 6951-6959.
18. Xu L, Hui AY, Albanis E, Arthur MJ, O'Byrne SM, et al. (2005) Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 54: 142-151. (Pubitemid 40007234)
19. Garcia MG, Bayo J, Bolontrade MF, Sganga L, Malvicini M, et al. (2011) Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo. Mol Pharm 8: 1538-1548.
20. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, et al. (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228. (Pubitemid 32295155)
21. Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE (2005) Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 23: 220-229. (Pubitemid 40239517)
22. Welinder C, Ekblad L (2011) Coomassie staining as loading control in Western blot analysis. J Proteome Res 10: 1416-1419.
23. Klopp AH, Gupta A, Spaeth E, Andreeff M, Marini F, 3rd (2011) Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem Cells 29: 11-19.
24. Ogata R, Torimura T, Kin M, Ueno T, Tateishi Y, et al. (1999) Increased expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 with tumor dedifferentiation in hepatocellular carcinomas. Hum Pathol 30: 443-450. (Pubitemid 29177825)
25. Silletti S, Watanabe H, Hogan V, Nabi IR, Raz A (1991) Purification of B16-F1 melanoma autocrine motility factor and its receptor. Cancer Res 51: 3507-3511.
26. Watanabe H, Carmi P, Hogan V, Raz T, Silletti S, et al. (1991) Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor. J Biol Chem 266: 13442-13448. (Pubitemid 21907364)
27. Ries C, Egea V, Karow M, Kolb H, Jochum M, et al. (2007) MMP-2, MT1- MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 109: 4055-4063. (Pubitemid 46641761)
28. Tondreau T, Meuleman N, Stamatopoulos B, De Bruyn C, Delforge A, et al. (2009) In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues. Cytotherapy 11: 559-569.
29. De Becker A, Van Hummelen P, Bakkus M, Vande Broek I, De Wever J, et al. (2007) Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica 92: 440-449. (Pubitemid 350144289)
30. Niess H, Bao Q, Conrad C, Zischek C, Notohamiprodjo M, et al. (2011) Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma. Ann Surg 254: 767-774; discussion774-765.
31. Gao Y, Yao A, Zhang W, Lu S, Yu Y, et al. (2010) Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice. Oncogene 29: 2784-2794.
32. Ponte AL, Marais E, Gallay N, Langonne A, Delorme B, et al. (2007) The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25: 1737-1745. (Pubitemid 47121852)
33. Kalwitz G, Endres M, Neumann K, Skriner K, Ringe J, et al. (2009) Gene expression profile of adult human bone marrow-derived mesenchymal stem cells stimulated by the chemokine CXCL7. Int J Biochem Cell Biol 41: 649-658.
34. Gao H, Priebe W, Glod J, Banerjee D (2009) Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cellderived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium. Stem Cells 27: 857-865.
35. Tapper J, Kettunen E, El-Rifai W, Seppala M, Andersson LC, et al. (2001) Changes in gene expression during progression of ovarian carcinoma. Cancer Genet Cytogenet 128: 1-6. (Pubitemid 32655473)
36. Yanagawa T, Watanabe H, Takeuchi T, Fujimoto S, Kurihara H, et al. (2004) Overexpression of autocrine motility factor in metastatic tumor cells: possible association with augmented expression of KIF3A and GDI-beta. Lab Invest 84: 513-522. (Pubitemid 41656479)
37. Tsutsumi S, Hogan V, Nabi IR, Raz A (2003) Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts. Cancer Res 63: 242-249. (Pubitemid 36070446)